Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Old Second Bancorp
OSBC
$1.29B
| $648K | ﹤0.01% |
36,438
-799
| -2% | -$13.9K |
|
1902
Celldex Therapeutics
CLDX
$2.94B
| $647K | ﹤0.01% |
25,642
| – | – |
|
1903
Liberty Live Group Series A
LLYVA
$9.21B
| $646K | ﹤0.01% |
9,700
| – | – |
|
1904
TripAdvisor
TRIP
$1.7B
| $643K | ﹤0.01% |
43,528
| – | – |
|
1905
Empire State Realty Trust
ESRT
$1B
| $642K | ﹤0.01% |
62,179
| – | – |
|
1906
Papa John's
PZZA
$1.01B
| $642K | ﹤0.01% |
15,622
| – | – |
|
|
TGI
1907
DELISTED
Triumph Group
TGI
| $642K | ﹤0.01% |
34,392
-6,700
| -16% | -$111K |
|
1908
Nelnet
NNI
$4.96B
| $641K | ﹤0.01% |
6,007
| – | – |
|
1909
Target Hospitality
TH
$1.43B
| $641K | ﹤0.01% |
66,295
+5,710
| +9% | +$47.7K |
|
1910
Wave Life Sciences
WVE
$1.12B
| $639K | ﹤0.01% |
51,700
| – | – |
|
1911
Tennant Co
TNC
$1.44B
| $639K | ﹤0.01% |
7,824
-18,151
| -70% | -$1.6M |
|
1912
Granite Ridge Resources
GRNT
$621M
| $637K | ﹤0.01% |
98,620
+22,071
| +29% | +$137K |
|
1913
Qorvo
QRVO
$7.9B
| $636K | ﹤0.01% |
9,095
-3,291
| -27% | -$263K |
|
1914
Globalstar
GSAT
$10.1B
| $636K | ﹤0.01% |
20,334
| – | – |
|
1915
RELX
RELX
$66.7B
| $635K | ﹤0.01% |
13,975
| – | – |
|
1916
Astrana Health
ASTH
$1.81B
| $633K | ﹤0.01% |
20,106
| – | – |
|
1917
Global Net Lease
GNL
$1.87B
| $633K | ﹤0.01% |
86,788
| – | – |
|
1918
Grid Dynamics Holdings
GDYN
$569M
| $632K | ﹤0.01% |
28,370
+12,200
| +75% | +$213K |
|
1919
Adeia
ADEA
$2.55B
| $632K | ﹤0.01% |
45,163
| – | – |
|
1920
Stepan Co
SCL
$1.5B
| $630K | ﹤0.01% |
9,745
| – | – |
|
|
TWO
1921
Two Harbors Investment
TWO
$1.27B
| $628K | ﹤0.01% |
53,040
| – | – |
|
1922
Employers Holdings
EIG
$907M
| $627K | ﹤0.01% |
12,241
| – | – |
|
1923
Delek US
DK
$3.98B
| $627K | ﹤0.01% |
33,860
| – | – |
|
1924
Immunovant
IMVT
$7.93B
| $625K | ﹤0.01% |
25,231
| – | – |
|
1925
DNOW Inc
DNOW
$2.44B
| $624K | ﹤0.01% |
47,975
| – | – |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.